Mira Pharmaceuticals Inc MIRA

$0.65 +0.03 (4.48%)

Valuation

Market cap
26,142,000
Revenue TTM
$0
Net income TTM
$-10,440,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
63,200
Avg volume
162,250
Day's range
$0.62 – $0.66
Shares out
42,022,000
Stochastic %K
92%
Beta
1.65
Analysts
Strong Buy
Price target
$8.00

Price

Company profile

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is u...

Show more

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
786 432 9792
Website
https://mirapharmaceuticals.com
Address
1200 Brickell Avenue, Suite 1950 #1183, Miami, United States

Latest news

Stocktwits

Jaespresso Nov 12, 3:04 PM
$MIRA $FGL I like these…
0 replies
Jaespresso Nov 12, 2:17 PM
$MIRA earnings today?
0 replies
Vincentes Nov 11, 4:47 PM
$MIRA
0 replies
Jaespresso Nov 11, 2:52 PM
$MIRA ⬆️
0 replies
DUherka Nov 10, 4:47 PM
go up babay! $MIRA
0 replies
Jaespresso Nov 9, 6:22 PM
$MIRA
0 replies
prismmarketview Nov 9, 4:16 PM
Can a non-opioid pill ease chemotherapy-induced nerve pain? MIRA Pharmaceuticals ($MIRA ) is preparing to find out. CEO Erez Aminov discusses Ketamir-2’s planned Phase 2a trial in early 2027, its first test in patients with the condition, and what’s next for the pipeline. https://prismmarketview.com/can-a-non-opioid-pill-ease-chemo-nerve-pain-mira-pharmaceuticals-is-about-to-find-out/
0 replies
Buder Nov 4, 9:48 PM
$MIRA added! 🤞
0 replies